UHenry Ji
USihlalo, uMongameli kunye ne-CEO
- Iminyaka engama-25+ yamava kwi-biotechnology kunye neshishini lesayensi yobomi
- UDkt Ji waseka i-Sorrento kwaye uye wakhonza njengomlawuli ukususela ngo-2006, i-CEO kunye noMongameli ukususela ngo-2012, kunye noSihlalo ukususela ngo-2017.
- Ngethuba lokuhlala kwakhe e-Sorrento, uye wenza ubunjineli kwaye wakhokela ukukhula okumangalisayo kwe-Sorrento ngokufunyanwa kunye nokudibanisa kuquka i-Bioserv, i-Scilex Pharmaceuticals, i-Concortis Biotherapeutics, i-Levena Biopharma, i-LACEL, i-TNK Therapeutics, i-Virttu Biologics, i-Ark Animal Health, kunye ne-Sofurysa Systems Lymphatic System.
- Usebenze njengeGosa eliyiNtloko lezeNzululwazi le-Sorrento ukusuka ngo-2008 ukuya ku-2012 nanjenge-CEO yayo yeThutyana ukusuka ngo-2011 ukuya ku-2012.
- Ngaphambi kwe-Sorrento, wayenezikhundla eziphezulu eziphezulu kwi-CombiMatrix, i-Stratagene kwaye waseka i-Stratagene Genomics, i-subsidiary ye-Stratagene, kwaye wasebenza njengoMongameli kunye ne-CEO kunye noMlawuli weBhodi.
- BS kunye nePh.D.
Vala >
UMike Royal
IGosa lezeMpilo
- UGqr Royal ungumphathi wamachiza kunye neminyaka eyi-20 yophuhliso lwezonyango kunye nemicimbi yezonyango. Kungekudala, wayeyiNtloko yezoNyango ze-Suzhou Connect Biopharmaceuticals kwaye, ngaphambi koko, i-Concentric Analgesics. Ubuyela eSorrento apho wayekade eyi-EVP, uPhuhliso lwezonyango kunye neMicimbi yoLawulo kwi-2016.
- Ube noxanduva okanye isixhobo kwii-NDA ezininzi eziyimpumelelo, kubandakanywa i-NCEs, i-505 (b) (2) kunye ne-ANDAs.
- UGqr Royal ibhodi eqinisekisiweyo kunyango lwangaphakathi, iyeza lentlungu, i-anesthesiology eneziqinisekiso ezongezelelweyo zokulawula iintlungu, iyeza lokulutha kunye neyeza lomthetho.
- Ube nguNjingalwazi oNcedisayo wezoNyango kwiYunivesithi yeeNkonzo zeSayensi yezeMpilo, uNjingalwazi oNcedisayo we-Anesthesiology / i-Critical Care Medicine kwiYunivesithi yasePittsburgh Medical Centre, kunye noNjingalwazi oNxibeleleyo kwiYunivesithi yase-Oklahoma kunye neYunivesithi yaseCalifornia eSan Diego.
- Upapashe ngokubanzi kunye nezahluko zencwadi ezingaphezu kwe-190, amanqaku ahlaziywe ngoontanga kunye nezishwankathelo / iipowusta; kwaye ube sisithethi esimenyiweyo kwiintlanganiso zesizwe nezamazwe ngamazwe
- BS, MD, JD, MBA
Vala >
Elizabeth Czerepak
USekela Mongameli oLawulayo, iGosa eliyiNtloko lezeziMali, iGosa eliyiNtloko lezoShishino
- Iminyaka engama-35+ yemali kunye namava okusebenza kwi-biotech kunye namayeza
- UNksz Czerepak uchithe iminyaka eyi-18 kwi-Pharma enkulu kunye neminyaka eyi-11 njenge-CFO ye-biotechs eyahlukeneyo, apho wayekhokela inkxaso-mali, intsebenziswano kunye nemizamo ye-M&A. Waqala umsebenzi wakhe kwi-Merck & Co., wadlala indima ephambili ekufumaneni i-Syntex ye-$ 5.4B ye-$ 6.8B, kwaye wakhokela iinzame zokubambisana ze-Humira® eziye zafikelela kwi-BASF Pharma's $ XNUMXB ye-Abbott.
- Kangangeminyaka elithoba njengoMlawuli oLawulayo eJP Morgan naseBear Stearns, wayeseka iqabane jikelele lengxowa-mali yephulo le-$212M, apho wayekhokele utyalo-mali kwii-biotechs ezili-13, esebenza kwiibhodi kwaye eququzelela ukuphuma nge-IPO kunye nokufumana. Uthotho lwe-7 kunye ne-Series 63 FINRA (NASD) Ummeli obhalisiweyo ukusuka kwi-2001 ukuya kwi-2008.
- Ilungu lebhodi elinamava (kubandakanya i-Sorrento kunye neScilex) kunye nosihlalo wophicotho-zincwadi, abafumana iSatifikethi soMlawuli weShishini kwiSikolo soShishino saseHarvard ngo-2020.
- I-BA kunye ne-MBA
Vala >
UMark R. Brunswick
USekela Mongameli oPhezulu kwiMicimbi yoLawulo
- UGqr Brunswick uneminyaka engaphezulu kwe-35 yezikhundla eziphezulu kwiShishini eliLawulwayo kuquka iminyaka engaphezu kwe-9 kwi-FDA yase-US, iZiko le-Biologics, iCandelo le-Monoclonal Antibodies.
- Ngaphambi kokujoyina i-Sorrento, uGqr. Brunswick wayeyiNtloko yeMicimbi yoLawulo kunye noMgangatho e-Sophiris Bio, inkampani ephuhlisa ichiza le-benign prostatic hyperplasia kunye nomhlaza wesinyi. Ngaphambi koko wayeyintloko yeMicimbi yoLawulo kwi-Arena Pharmaceuticals egxile kunyango olujoliswe kwi-G Protein receptors.
- UDkt Brunswick ukhokele iqela elilawulayo kwi-Elan Pharmaceuticals egxile kwi-Alzheimer Disease kunye ne-compound yentlungu, i-ziconotide.
- BS kunye nePh.D.
Vala >
Xiao Xu
UMongameli ACEA
- UGqr. Xu uneminyaka engaphezu kwama-20 yamava njengomphathi kumashishini ebhayoloji. UGqr. Xu wayengumseki, umongameli kunye ne-CEO ye-ACEA Biosciences (efunyenwe yi-Agilent ngo-2018) kunye ne-ACEA Therapeutics (efunyenwe ngu. Sorrento Therapeutics ngo-2021). Uyajoyina Sorrento Therapeutics emva kokufunyanwa, kwaye iyaqhubeka nokusebenza njengoMongameli we-ACEA, i-subsidiary ye Sorrento Therapeutics.
- Ebelawula kwaye enoxanduva lophuhliso lwemibhobho yamachiza e-ACEA, izifundo zeklinikhi, kunye neziko lokwenziwa kwe-cGMP.
- Wayengumqambi weteknoloji ye-assay esekelwe kwileyibhile yasimahla kunye noxanduva lwetekhnoloji / uphuhliso lwemveliso kunye nentsebenziswano yeshishini kunye ne-Roche Diagnosis, urhwebo lwehlabathi lwetekhnoloji yobunini be-ACEA kunye neemveliso, kunye ne-250 yezigidi zeedola zokufunyanwa kwe-Agilent ye-ACEA Biosciences.
- Ube ngumphandi wabasebenzi kunye nososayensi wophando kwiiGladstone Institutes, i-Scripps Research Institute kunye ne-US Centres for Disease Control and Prevention. Ungumnini wamalungelo awodwa omenzi wechiza angaphezulu kwama-50 ase-US kunye nezicelo zelungelo elilodwa lomenzi wechiza kwaye upapashe amanqaku ophando angaphezu kwama-60 kwiijenali zamazwe ngamazwe, kuquka iSayensi, i-PNAS, iNature Biotechnology, kunye neKhemistri kunye neBhayoloji.
- BS, MS, kunye neMD
Vala >
UShawn Sahebi
USekela Mongameli oPhezulu kwiMisebenzi yoRhwebo
- UGqr. Sahebi ukhokela imisebenzi yentengiso ye-Sorrento
- Izisa iminyaka engaphezulu kwe-30 yamava amayeza kubandakanya isayensi yokuthengisa kunye nesicwangciso sorhwebo eSorrento
- Ngaphambi kokujoyina i-Sorrento, wayephethe izikhundla eziphezulu zolawulo kunye noNovartis, uPfizer, kunye noLilly bephuhlisa uhlalutyo lwezorhwebo kunye nedatha yedatha yendlela yokuthengisa ejongene nokukhula okubalulekileyo kweemveliso ze-20 ezifikelela kwi-blockbuster status kwiindawo ze-Cardiovascular, Arthritis, Neuroscience, Diabetes, kunye ne-Oncology.
- Ikholwa eliqinileyo lokuba iinkcubeko ezisebenzisanayo zidala amaqela aphumeleleyo
- Umongameli odlulileyo, uMbutho weNzululwazi yoLawulo lwezamayeza eMelika
- BA, MBA kunye nePh.D.
Vala >
UBrian Cooley
USekela Mongameli oPhezulu, uNxibelelwano loShishino kunye noPhuhliso lweLymphatic Drug BU
- Iminyaka engama-30+ yamava kwishishini le-biopharmaceutical kunye nesayensi yobomi
- UMnu. Cooley ubambe izikhundla ezahlukeneyo zokuthengisa, ukuthengisa, kunye nobunkokeli bezorhwebo kwiinkampani zethamsanqa ezingama-500 kwaye ukhokele ukunyusa imali ngempumelelo kunye nokuqalisa iinzame zeenkampani zobuchwepheshe bokhathalelo lwempilo.
- Ngaphambi kokujoyina i-Sorrento, uMnumzana Cooley ukhokele intengiso yehlabathi jikelele iinzame zokuphehlelelwa kwemveliso entsha ngoxanduva lwe-P&L kuzo zombini ii-Eli Lilly kunye neNkampani kunye neGenentech kwiindawo zesifo ezibandakanya i-Diabetes, Neurology, Immunology kunye neSifo esinqabileyo.
- Ukongeza, uye wakhokelela i-BD ebalulekileyo, ilayisensi, kunye neenzame zokudibanisa kumazwe ngamazwe nase-US Oku kubandakanya izivumelwano ezininzi zokwandisa ishishini eYurophu, kuMbindi Mpuma kunye ne-Afrika, kunye nesivumelwano sokusebenzisana se-$ 400MM kwi-ilayisensi, ukuphuhlisa kunye nokuthengisa. I-agonist yokuqala ye-GLP-1
- Kutshanje, uMnu. Cooley ebeyi-CBO yeCandelo loShishino lweSofusa eKimberly-Clark kwaye ukhokele ukuthengisa ngempumelelo kunye nomzamo wokudibanisa Sorrento Therapeutics. Uyaqhubeka ekhokela icandelo leLymphatic Drug Delivery systems eSorrento.
- BS
Vala >
UBill Farley
USekela Mongameli woPhuhliso loShishino
- Iminyaka engama-30+ yamava kuPhuhliso lweShishini, uThengiso kunye neenzame ezikhokelayo ekufumaneni iziyobisi, uphuhliso kunye nentsebenziswano
- Ngaphambi kokujoyina i-Sorrento, uMnu. Farley uye wabamba izikhundla zobunkokeli kwi-HitGen, i-WuXi Apptec, i-VP ye-Key Accounts building kunye nokukhokela iqela le-BD yehlabathi jikelele; I-ChemDiv, i-VP ye-BD, ekhokela iinzame ezininzi zokudala iinkampani ezintsha zonyango kwi-CNS, i-Oncology kunye ne-Anti-infectives.
- UMnu. Farley usebenze njengomcebisi kumaqela alawulayo ahlukeneyo kunye neeBODs ukuphuhlisa nokuthengisa asethi ezifana neXencor, Caliper Technologies kunye neStratagene.
- Uye wakha inethiwekhi eyomeleleyo kuzo zonke iinkampani zamayeza, i-biotech kunye noluntu lweVenture Capital. UMnu. Farley uthethe kwiinkomfa ezininzi kwaye upapashwe kwiijenali ezahlukeneyo eziphononongwe ngabalingane
- BS
Vala >
Alexis Nahama
USekela Mongameli oPhezulu Neurotherapeutics BU
- UGqr. uNahama ukhokela iinkqubo zeRTX zophuhliso lwamachiza empilo yabantu nezilwanyana
- Njengeqela lobunkokheli belungu, uGqr. Nahama uxhasa uphuhliso lweqhinga, ujongana neeprojekthi zexabiso eliphezulu, uququzelela ukuya kulungiselelo lwentengiso, kwaye ukhulise iinzame zomanyano lwangaphandle.
- Ngomdla uqhuba amathuba okuguqulela ukukhawulezisa iinkqubo zophuhliso loluntu ngelixa sizisa itekhnoloji ebingenakufumaneka kwizilwanyana zasekhaya.
- Ngaphambi kokujoyina iSorrento, uchithe ngaphezulu kweminyaka engama-25 ebambe iindima zesigqeba zehlabathi esebenza kwiSayensi yoBomi kunye neBiotechnology yeSanofi, Colgate, Novartis, Merck, VCA Antech kunye neVetStem Biopharma.
- I-DVM enomsebenzi wokuqala igxile kwi-R&D kwindawo yeentlungu (ulingo lwezonyango lwezilwanyana zasekhaya)
Vala >
I-10bio ihamba apha10: i-dangler l = 5